Victor Golmer/iStock Editorial via Getty Images
- BioNTech (NASDAQ:BNTX) Chief Strategy Officer Ryan Richardson will leave that position on Sept. 30 to pursue another opportunity.
- He will also resign as a board member of BioNTech affiliated companies.
- Richardson joined the German biotech in 2018 and became chief strategy officer in January 2020.
- During his tenure, he oversaw BioNTech’s Series B financing, IPO, and follow-on equity financings.
More on BioNTech
- BioNTech: More Uncertainty Emerges
- BioNTech’s Acquisition Of CureVac Brings Complementary Method To Target Cancer
- Bristol-Myers And BioNTech Deal: Good For Both Parties, But One Is The Better Investment
- Pfizer, BioNTech challenge Moderna’s COVID vaccine patent win in U.K.
- RFK Jr. sued by doctor, health groups over changes to COVID shot recommendations